Lenarczyk Radosław, Woźniak Aleksandra, Kowalski Oskar, Sokal Adam, Pruszkowska-Skrzep Patrycja, Sredniawa Beata, Szulik Mariola, Zielińska Teresa, Kukulski Tomasz, Stabryła Joanna, Mazurek Michał, Białkowski Jacek, Kalarus Zbigniew
Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Medical University of Silesia, Silesian Center for Heart Disease, Zabrze, Poland.
Pacing Clin Electrophysiol. 2011 Nov;34(11):1544-52. doi: 10.1111/j.1540-8159.2011.03193.x.
The purpose of this study was to assess the effectiveness of cardiac resynchronization therapy (CRT) in terms of outflow tract gradient reduction and functional improvement in symptomatic patients with hypertrophic obstructive cardiomyopathy (HOCM) requiring implantable cardioverter-defibrillator (ICD) implantation.
Eleven consecutive symptomatic HOCM patients with a significant (≥40 mmHg) gradient and indications for ICD, but without indications for resynchronization, underwent CRT-D implantation. Nine of them (four female, median age of 50 years) in whom the procedure succeeded were screened for New York Heart Association (NYHA) class, outflow gradient, mechanical dyssynchrony, QRS-width change, and 6-minute walking distance (6MWD) and peak oxygen consumption (VO(2)peak) improvement after 6 months and remotely.
After 6 months of pacing, NYHA class decreased (median 1 vs 2, respectively); peak (33 vs 84 mmHg) and mean (13 vs 38 mmHg) outflow tract gradients were reduced; and QRS width (143 vs 105 ms), intraventricular dyssynchrony (35 vs 55 ms), and VO(2)peak (19.5 vs 14.2 mL/kg/min) increased significantly (all P < 0.05) compared to baseline. In six of nine patients (67%), the peak gradient was reduced >50% and reached <40 mmHg. After a median of 36 months, the outflow gradient decreased even more (8 mmHg) and was significantly (P < 0.05) lower than after 6 months of CRT.
These preliminary data suggest that CRT seems to be an effective method of reducing the outflow tract gradient and improving the functional status of symptomatic HOCM patients requiring ICD implantation. Our findings need to be confirmed by more extensive studies.
本研究旨在评估心脏再同步治疗(CRT)对于有症状的肥厚性梗阻性心肌病(HOCM)患者在降低流出道梯度及改善功能方面的有效性,这些患者需要植入植入式心律转复除颤器(ICD)。
连续11例有症状的HOCM患者,其梯度显著(≥40 mmHg)且有ICD植入指征,但无再同步指征,接受了CRT-D植入。其中9例手术成功的患者(4例女性,中位年龄50岁),在6个月后及远程评估时,对其纽约心脏协会(NYHA)分级、流出道梯度、机械性不同步、QRS波宽度变化、6分钟步行距离(6MWD)及峰值耗氧量(VO₂峰值)改善情况进行了筛查。
起搏6个月后,NYHA分级降低(中位数分别为1级和2级);峰值(33 mmHg对84 mmHg)和平均(13 mmHg对38 mmHg)流出道梯度降低;与基线相比,QRS波宽度(143 ms对105 ms)、心室内不同步(35 ms对55 ms)及VO₂峰值(19.5 mL/kg/min对14.2 mL/kg/min)显著增加(均P < 0.05)。9例患者中有6例(67%)峰值梯度降低>50%且降至<40 mmHg。中位随访36个月后,流出道梯度进一步降低(8 mmHg),且显著低于CRT治疗6个月后(P < 0.05)。
这些初步数据表明,CRT似乎是降低有症状的需要植入ICD的HOCM患者流出道梯度及改善功能状态的有效方法。我们的研究结果需要通过更广泛的研究来证实。